{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:19:43Z","timestamp":1765545583705},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T00:00:00Z","timestamp":1250035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Common variable immunodeficiency (CVID) is a heterogeneous syndrome characterized by defective immunoglobulin production and high frequency of bacterial infections, autoimmunity and manifestations of chronic inflammation. The homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 are associated with modulation of inflammatory responses. CVID patients have decreased proportions of CCR7+ T cells in peripheral blood and we hypothesized a further dysregulation of CCL19\/CCL21\/CCR7 in CVID. Serum levels of CCL19 and CCL21 were compared in CVID patients and controls. T cell expression of CCR7 was related to clinical characteristics in CVID patients. Spleens extirpated from CVID patients were analysed for expression of CCL19, CCL21 and CCR7. Peripheral blood mononuclear cells (PBMC) from CVID patients and controls were analysed for cytokine response on stimulation with CCL19 and CCL21. The main findings were: (i) CVID patients have raised serum levels of CCL19 and CCL21 independently of features of chronic inflammation; (ii) CCL19 and CCR7 have similar expression in spleens from CVID patients and controls, while CCL21 is variably down-regulated in spleens from patients; (iii) T cell expression of CCR7 is particularly low in patients characterized by chronic inflammation in vivo; and (iv) PBMC from CVID patients had attenuated cytokine response to stimulation with CCL19 and CCL21. CVID patients have raised circulatory levels of CCL19 and CCL21, and an attenuated cytokine response to stimulation with these chemokines. Because CCR7, CCL19 and CCL21 are key mediators balancing immunity and tolerance in the immune system, the abnormalities of these mediators might contribute to the profound immune dysregulation seen in CVID.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2009.04013.x","type":"journal-article","created":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T12:01:05Z","timestamp":1250078465000},"page":"237-245","source":"Crossref","is-referenced-by-count":11,"title":["Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation"],"prefix":"10.1093","volume":"158","author":[{"given":"B","family":"Fevang","sequence":"first","affiliation":[{"name":"Research Institute for Internal Medicine, Rikshospitalet University Hospital and University of Oslo, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Yndestad","sequence":"additional","affiliation":[{"name":"Research Institute for Internal Medicine, Rikshospitalet University Hospital and University of Oslo, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J K","family":"Dam\u00e5s","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St Olav's Hospital, Trondheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Halvorsen","sequence":"additional","affiliation":[{"name":"Research Institute for Internal Medicine, Rikshospitalet University Hospital and University of Oslo, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Holm","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Beiske","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Aukrust","sequence":"additional","affiliation":[{"name":"Research Institute for Internal Medicine, Rikshospitalet University Hospital and University of Oslo, Oslo"},{"name":"Section of Clinical Immunology and Infectious Diseases, Rikshospitalet University Hospital, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S S","family":"Fr\u00f8land","sequence":"additional","affiliation":[{"name":"Research Institute for Internal Medicine, Rikshospitalet University Hospital and University of Oslo, Oslo"},{"name":"Section of Clinical Immunology and Infectious Diseases, Rikshospitalet University Hospital, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,8,12]]},"reference":[{"issue":"1","key":"2021122708524651100_b1","first-page":"1","article-title":"Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological societies","volume":"118","author":"Rosen","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2021122708524651100_b2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122708524651100_b3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"Forster","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2021122708524651100_b4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1600-065X.2003.00073.x","article-title":"The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity","volume":"195","author":"Muller","year":"2003","journal-title":"Immunol Rev"},{"key":"2021122708524651100_b5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2002-05-1586","article-title":"Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases","volume":"101","author":"Christopherson","year":"2003","journal-title":"Blood"},{"key":"2021122708524651100_b6","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.4049\/jimmunol.170.9.4638","article-title":"Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis","volume":"170","author":"Weninger","year":"2003","journal-title":"J Immunol"},{"key":"2021122708524651100_b7","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.4049\/jimmunol.174.3.1693","article-title":"A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis","volume":"174","author":"Burman","year":"2005","journal-title":"J Immunol"},{"key":"2021122708524651100_b8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/gut.2004.063008","article-title":"Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism","volume":"55","author":"Middel","year":"2006","journal-title":"Gut"},{"key":"2021122708524651100_b9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.ATV.0000255581.38523.7c","article-title":"Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization","volume":"27","author":"Damas","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021122708524651100_b10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2249.2004.02630.x","article-title":"Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells","volume":"138","author":"Holm","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"2021122708524651100_b11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2005.11.011","article-title":"CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation","volume":"119","author":"Viallard","year":"2006","journal-title":"Clin Immunol"},{"key":"2021122708524651100_b12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clim.2006.07.003","article-title":"Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients","volume":"121","author":"Moratto","year":"2006","journal-title":"Clin Immunol"},{"key":"2021122708524651100_b13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.1992.tb06934.x","article-title":"Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features","volume":"89","author":"Aukrust","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"2021122708524651100_b14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/clin.1994.1032","article-title":"Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes","volume":"70","author":"Aukrust","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"2021122708524651100_b15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2249.1994.tb06073.x","article-title":"Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency","volume":"97","author":"Aukrust","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"2021122708524651100_b16","first-page":"691","article-title":"Bronchiectasis: not an orphan disease in the East","volume":"8","author":"Tsang","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"2021122708524651100_b17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clim.2008.09.002","article-title":"Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1\/CX3CR1) to chronic inflammation","volume":"130","author":"Fevang","year":"2009","journal-title":"Clin Immunol"},{"key":"2021122708524651100_b18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jlb.57.2.235","article-title":"Retention of phagocytic functions in cryopreserved human monocytes","volume":"57","author":"Hansen","year":"1995","journal-title":"J Leukoc Biol"},{"key":"2021122708524651100_b19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.193.2.207","article-title":"Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses","volume":"193","author":"Mori","year":"2001","journal-title":"J Exp Med"},{"key":"2021122708524651100_b20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1084\/jem.20061405","article-title":"CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells","volume":"204","author":"Schneider","year":"2007","journal-title":"J Exp Med"},{"key":"2021122708524651100_b21","doi-asserted-by":"crossref","first-page":"23214","DOI":"10.1074\/jbc.M402125200","article-title":"Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1\/2 activation by the two endogenous ligands for the CC chemokine receptor 7","volume":"279","author":"Kohout","year":"2004","journal-title":"J Biol Chem"},{"key":"2021122708524651100_b22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cellimm.2004.12.006","article-title":"The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells","volume":"231","author":"Flanagan","year":"2004","journal-title":"Cell Immunol"},{"key":"2021122708524651100_b23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.immuni.2005.02.010","article-title":"CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells","volume":"22","author":"Marsland","year":"2005","journal-title":"Immunity"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2009.04013.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/158\/2\/237\/41925667\/j.1365-2249.2009.04013.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/158\/2\/237\/41925667\/j.1365-2249.2009.04013.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:21:50Z","timestamp":1641054110000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/158\/2\/237\/6438842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,12]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,8,12]]},"published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2009.04013.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,11]]},"published":{"date-parts":[[2009,8,12]]}}}